A Novel Dose Constraint to Reduce Xerostomia in Head-and-Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 269-276

  Strigari, Lidia ^a   Benassi, Marcello ^a   Arcangeli, Giorgio ^a   Bruzzaniti, Vicente ^a   Giovinazzo, Giuseppe ^a   Marucci, Laura ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Dose constraint; Major salivary gland; Quality of life; Salivary flow recovery; Xerostomia

Indexed keywords

BONFERRONI METHOD; DESCRIPTIVE STATISTICS; DOSE-VOLUME HISTOGRAMS; HEAD-AND-NECK CANCER; INTENSITY-MODULATED RADIOTHERAPY; MEAN DOSE; MULTI VARIATE ANALYSIS; MULTIPLE COMPARISON; NASOPHARYNGEAL CANCER; PAROTID GLANDS; PRE-TREATMENT; PROGNOSTIC FACTORS; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION THERAPY ONCOLOGY GROUPS; SALIVARY FLOW; SALIVARY GLANDS; SUBMANDIBULAR GLANDS; UNIVARIATE; UNIVARIATE ANALYSIS; XEROSTOMIA;

DECISION MAKING; DIFFRACTION GRATINGS; DOSIMETRY; MULTIVARIANT ANALYSIS; ONCOLOGY; PATIENT MONITORING; SONOCHEMISTRY; SURVEYS; TOXICITY;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; FEMALE; HEAD AND NECK CANCER; HISTOGRAM; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX CANCER; PAROTID GLAND; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SALIVATION; SUBMANDIBULAR GLAND; XEROSTOMIA;

ANALYSIS OF VARIANCE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; PAROTID GLAND; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECOVERY OF FUNCTION; SALIVATION; SUBMANDIBULAR GLAND; TIME FACTORS; XEROSTOMIA;

EID: 77950550414     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.1734     Document Type: Article

References (39)

1. Boyer A.L., Geis P., Grant W., et al. Modulated beam conformal therapy for head and neck tumors. Int J Radiat Oncol Biol Phys 39 (1997) 227-236
2. De Neve W., De Gersem W., Derycke S., et al. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 50 (1999) 301-314
3. Eisbruch A., Marsh L.H., Martel M.K., et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and non-involved tissue sparing. Int J Radiat Oncol Biol Phys 41 (1998) 559-568
4. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48 (2000) 711-722
5. Van Dieren E.B., Nowak P.J.C.M., Wijers O.B., et al. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy in cancer of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys 47 (2000) 1299-1309
6. Verellen D., Linthout N., van den Berge D., et al. Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. Int J Radiat Oncol Biol Phys 39 (1997) 99-114
7. Wu Q., Manning M., Schmidt-Ullrich R., et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity modulated radiation treatments of head and neck cancer: A treatment design study. Int J Radiat Oncol Biol Phys 46 (2000) 195-205
8. Lee A.W., Sze W.M., Au J.S., et al. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience. Int J Radiat Oncol Biol Phys 61 (2005) 1107-1116
9. Chao K.S., Wippold F.J., Ozyigit G., et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53 (2002) 1174-1184
10. Marks J.E., Davis C.C., Gottsman V.L., et al. The effects of radiation of parotid salivary function. Int J Radiat Oncol Biol Phys 7 (1981) 1013-1019
11. Leslie M.D., and Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol 30 (1994) 26-32
12. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
13. Eisbruch A., Ten Haken R.K., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
14. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
15. Murdoch-Kinch C.A., Kim H.M., Vineberg K.A., et al. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 373-382
16. Edgar W.M. Saliva and dental health. Clinical implications of saliva: Report of a consensus meeting. Br Dent J 169 (1990) 96-98
17. In: Roth G., and Calmes R. (Eds). Salivary glands and saliva. In: Oral biology (1981), CV Mosby, St Louis 196-236
18. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
19. Bjordal K., Kaasa S., and Mastekaasa A. Quality of life in patients treated for head and neck cancer: A follow up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 847-856
20. Harrison L.B., Zelefski M.J., Pfitzer D.G., et al. Detailed quality of life assessment in patients with primary radiotherapy for cancer of the base of tongue. Head Neck 19 (1997) 169-175
21. Meirovitz A., Murdoch-Kinch C.A., Scipper M., et al. Grading xerostomia by physicians or by patients after IMRT. Int J Radiat Oncol Biol Phys 66 (2006) 445-453
22. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity modulated or conventional radiotherapy: Randomized study. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
23. Blanco A.I., Chao K.S.C., El Naqa I., et al. Dose-volume modelling of salivary function in patients with head and neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1055-1069
24. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
25. Parliament M.B., Scrimger R.A., Anderson S.G., et al. Preservation of oral health-related quality of life and salivary flow rates after IMRT. Int J Radiat Oncol Biol Phys 58 (2004) 663-673
26. Fox P.C., Busch K.A., and Baum B.J. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 115 (1987) 581-584
27. Franzen L., Funegard U., Ericson T., et al. Parotid gland function during and following radiotherapy. Eur J Cancer 28 (1992) 457-462
28. Atkinson J.C., and Fox P.C. Salivary gland disfunction. Clin Geriatr Med 8 (1992) 499-511
29. Strigari L., D'Andrea M., Abate A., et al. A heterogeneous dose distribution in simultaneous integrated boost: The role of the clonogenic cell density on the tumor control probability. Phys Med Biol 53 (2008) 5257-5273
30. Amosson C.M., Teh B.S., Van T.J., et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys 56 (2003) 136-144
31. R Development Core Team. R: A language and environment for statistical computing (2008), R Foundation for Statistical Computing, Vienna
32. Peterson D., and Sonis S. Oral complication of cancer chemotherapy. Dev Oncol 12 (1983) 80-118
33. Humphrey S.P., and Williamson R.T. A review of saliva: Normal composition, flow, and function. J Prosthet Dent 85 (2001) 162-169
34. Sprangers M.A., and Schwartz C.E. Integrating response shift into health-related quality of life research: A theoretical model. Soc Sci Med 48 (1999) 1507-1515
35. Lee E.K., Fox T., and Crocker I. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 64 (2006) 301-320
36. Astreinidou E., Dehnad H., Terhaard C.H.J., et al. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 58 (2004) 124-131
37. Jellema A.P., Doornaert P., Slotman B.J., et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171
38. Houweling A.C., Dijkema T., Roesink J.M., et al. Sparing the contralateral submandibular gland in oropharyngeal cancer patients: A planning study. Radiother Oncol 89 (2008) 64-70
39. Cox D.R., and Snell E.J. Analysis of binary data (1989), Chapman and Hall, New York p. 140